Metrics as of 10/16/2026, 01:51 AM (Berlin time), refresh in progress.
Cytosorbents Stock
Cytosorbents Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Phillip Chan
- Employees
- 129
- Market cap
- $10 M
- IPO
- 08/08/2006
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorbent and porous polymer technology. The company's leading product, CytoSorb, is an extracorporeal filter designed to…
Cytosorbents stock: price history
1D
-1.0%
1W
-18.0%
1M
-49.5%
6M
-74.9%
YTD
-76.1%
1Y
-83.3%
2Y
-86.0%
5Y
-97.4%
10Y
-97.3%
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~21% weaker price swings than usual
Ask the agents about Cytosorbents
Analyst assessment of Cytosorbents
0
STRONG BUY
12
BUY
1
HOLD
0
SELL
0
STRONG SELL
13
TOTAL · Buy
As of: 26/03/2026
Cytosorbents stock metrics
P/E
-0.53
P/B
-12.8
EV/EBITDA
-2.26
RETURN ON EQUITY
588.1%
NET MARGIN
-45.9%
DEBT/EQUITY
-35.07
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
86.0%
FLOAT SHARES
2,709,442
AVG. DAILY VOLUME (30D)
13,459
Insider transactions (SEC)
Chan Phillip P.
Sobel Alan D.
Sobel Alan D.
Capponi Vincent
Capponi Vincent
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Cytosorbents stock
What does Cytosorbents do?
Cytosorbents Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Phillip Chan, the company employs around 129 people.
The IPO was on 08/08/2006; the stock trades on NASDAQ under the ticker CTSO.
What do analysts say about Cytosorbents stock?
13 analysts rate the stock, the consensus is Buy (as of 26/03/2026).
This is an external assessment, not a statement by Market Jury.
When does Cytosorbents report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly -21% stronger than usual.
Does Cytosorbents pay a dividend?
No, Cytosorbents currently does not pay a dividend.
Which stocks are comparable to Cytosorbents?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Cytosorbents stock analyzed?
Clicking "Analyze stock" lets five strategies assess Cytosorbents against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.